Nordson Corporation (NDSN) reported its Q4 2025 Earnings, which surpassed Wall Street estimates and set a record for both sales and earnings per share (EPS) growth. The corporation anticipates a 6%-12% adjusted EPS growth for 2026. Despite missing Q3 sales expectations, Nordson's shares have been acquired by Curi Capital LLC and others, showing investor confidence. The corporation offers an upcoming dividend of US$0.82. Nordson's Q4 results demonstrated record EBITDA margins, yet some mixed signals have been observed. Institutional shareholders control 79% of Nordson, and a strong 2026 guidance has driven shares upwards. Despite a moderate return potential, the corporation’s strong multi-year run continues and has led to a premium valuation. Nordson has reported both its Q1 2026 and FY 2026 earnings guidance and raised its stock price target to $295. Other highlights include Nordson MEDICAL's divestiture of select contract manufacturing products and a strong uptake of NDSN shares by numerous firms. It has also been noted that Nordson stock offers steady returns as dividend stocks. However, Nordson EVP DeVries recently sold $2.13m in NDSN stock.
Nordson Corp NDSN News Analytics from Fri, 30 May 2025 07:00:00 GMT to Sat, 13 Dec 2025 13:07:58 GMT - Rating 8 - Innovation 6 - Rumor -2
